000 01566 a2200457 4500
005 20250518080100.0
264 0 _c20200604
008 202006s 0 0 eng d
022 _a1873-2623
024 7 _a10.1016/j.transproceed.2019.10.016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBayraktar, Adem
245 0 0 _aCan Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?
_h[electronic resource]
260 _bTransplantation proceedings
_c
300 _a97-101 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAntiviral Agents
_ximmunology
650 0 4 _aAutoantibodies
_xdrug effects
650 0 4 _aCadaver
650 0 4 _aFemale
650 0 4 _aHepacivirus
_ximmunology
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aKidney Transplantation
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aViremia
_xdrug therapy
650 0 4 _aWaiting Lists
700 1 _aAkgül, Sebahat Usta
700 1 _aBakkaloğlu, Hüseyin
700 1 _aTemurhan, Sonay
700 1 _aÇınar, Çiğdem Kekik
700 1 _aÇiftçi, Hayriye Şentürk
700 1 _aKaan Gök, Ali Fuat
700 1 _aDemir, Erol
700 1 _aOğuz, Fatma Savran
700 1 _aTürkmen, Aydın
773 0 _tTransplantation proceedings
_gvol. 52
_gno. 1
_gp. 97-101
856 4 0 _uhttps://doi.org/10.1016/j.transproceed.2019.10.016
_zAvailable from publisher's website
999 _c30483285
_d30483285